Bio Green Med Solution (BGMS) Interest Coverage Ratio (2010)
Bio Green Med Solution (BGMS) posted quarterly Interest Coverage Ratio of 17.68 for Q1 2026, up 98.32% year-over-year from 8.92 in Q1 2025, and up 98.37% quarter-over-quarter from 1082.0 in Q4 2025.
Analysis
Bio Green Med Solution (BGMS) Interest Coverage Ratio (2010) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Interest Coverage Ratio for 17 consecutive years, with 17.68 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 98.32% year-over-year to 17.68; the TTM figure through Mar 2026 stood at 174.41 (down 6.93% YoY), while the FY2025 annual figure was 2.05, up 98.05% from the prior year.
- Interest Coverage Ratio improved to 17.68 in Q1 2026 per BGMS's latest filing, from 1082.0 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 17.68 in Q1 2026 and bottomed at 1082.0 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 285.5 across 5 years, with a median of 76.08 in 2022.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio slumped 15229.55% — and 2026, when it jumped 98.32%.
- Bio Green Med Solution's Interest Coverage Ratio stood at 182.33 in 2022, then soared by 38.44% to 112.24 in 2023, then slumped by 738.65% to 941.3 in 2024, then dropped by 14.95% to 1082.0 in 2025, then soared by 98.37% to 17.68 in 2026.
- Business Quant data shows BGMS's Interest Coverage Ratio at 17.68 in Q1 2026, 1082.0 in Q4 2025, and 35.43 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 1.42 |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -0.08 |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | -767.33 |
| Sep 30, 2010 | -571.14 |
| Jun 30, 2010 | -487.33 |